脑瘫患者肌张力障碍减轻的证据仍然有限。
Evidence for dystonia reduction in cerebral palsy remains limited.
作者信息
Lumsden Daniel E
机构信息
Complex Motor Disorder Service, Children's Neurosciences, Evelina London Children's Hospital, London, UK.
出版信息
Dev Med Child Neurol. 2024 Sep;66(9):1116-1117. doi: 10.1111/dmcn.15923. Epub 2024 Apr 19.
Abstract
This commentary is on the clinical practice guideline by Fehlings et al. on pages 1133–1147 of this issue.
摘要
本述评是关于费林斯等人在本期第1133 - 1147页的临床实践指南。
相似文献
1
Evidence for dystonia reduction in cerebral palsy remains limited.脑瘫患者肌张力障碍减轻的证据仍然有限。
Dev Med Child Neurol. 2024 Sep;66(9):1116-1117. doi: 10.1111/dmcn.15923. Epub 2024 Apr 19.
2
Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy.苯海索治疗脑瘫继发性肌张力障碍患儿的前瞻性开放标签临床试验。
J Child Neurol. 2007 May;22(5):530-7. doi: 10.1177/0883073807302601.
3
Trihexyphenidyl for dystonia in cerebral palsy.用于治疗脑瘫肌张力障碍的苯海索
Cochrane Database Syst Rev. 2018 May 15;5(5):CD012430. doi: 10.1002/14651858.CD012430.pub2.
4
Deep brain stimulation for dystonia due to cerebral palsy: A review.脑性瘫痪所致肌张力障碍的深部脑刺激：综述。
Eur J Paediatr Neurol. 2018 Mar;22(2):308-315. doi: 10.1016/j.ejpn.2017.12.002. Epub 2017 Dec 14.
5
Deep brain stimulation for the treatment of childhood dystonic cerebral palsy.深部脑刺激治疗儿童肌张力障碍型脑瘫。
J Neurosurg Pediatr. 2014 Dec;14(6):585-93. doi: 10.3171/2014.8.PEDS141. Epub 2014 Oct 17.
6
The importance of dystonia in cerebral palsy.肌张力障碍在脑瘫中的重要性。
Eur J Paediatr Neurol. 2021 May;32:A3. doi: 10.1016/j.ejpn.2021.05.003. Epub 2021 May 4.
7
Correspondence on "Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy".关于“苯海索治疗脑性瘫痪继发肌张力障碍患儿的前瞻性开放标签临床试验”的通信
J Child Neurol. 2008 Jul;23(7):846; author reply 846-7. doi: 10.1177/0883073808316369.
8
Physician Approaches to the Pharmacologic Treatment of Dystonia in Cerebral Palsy.医师对脑性瘫痪中肌张力障碍的药物治疗方法
Pediatrics. 2024 Jul 1;154(1). doi: 10.1542/peds.2023-065512.
9
Future directions for the assessment of gait dystonia in cerebral palsy.
Dev Med Child Neurol. 2023 Jul;65(7):865-866. doi: 10.1111/dmcn.15523. Epub 2023 Jan 30.
10
Dystonia due to cerebral palsy responds to deep brain stimulation of the globus pallidus internus.脑性瘫痪导致的肌张力障碍对苍白球 internus 的深部脑刺激有反应。
Mov Disord. 2011 Aug 1;26(9):1748-51. doi: 10.1002/mds.23723. Epub 2011 Apr 12.
本文引用的文献
1
Pharmacological and neurosurgical management of cerebral palsy and dystonia: Clinical practice guideline update.脑性瘫痪和肌张力障碍的药理学及神经外科治疗：临床实践指南更新
Dev Med Child Neurol. 2024 Sep;66(9):1133-1147. doi: 10.1111/dmcn.15921. Epub 2024 Apr 19.
2
Pharmacological management of abnormal tone and movement in cerebral palsy.脑瘫异常姿势和运动的药物治疗管理。
Arch Dis Child. 2019 Aug;104(8):775-780. doi: 10.1136/archdischild-2018-316309. Epub 2019 Apr 4.
3
Pharmacological and neurosurgical interventions for managing dystonia in cerebral palsy: a systematic review.药物和神经外科干预治疗脑性瘫痪的肌张力障碍：系统评价。
Dev Med Child Neurol. 2018 Apr;60(4):356-366. doi: 10.1111/dmcn.13652. Epub 2018 Feb 6.
4
Oral medication prescription practices of tertiary-based specialists for dystonia in children with cerebral palsy.以三级医疗机构为基础的专家对脑瘫患儿肌张力障碍的口服药物处方实践。
J Paediatr Child Health. 2018 Apr;54(4):401-404. doi: 10.1111/jpc.13754. Epub 2017 Nov 6.
5
GRADE: an emerging consensus on rating quality of evidence and strength of recommendations.GRADE：关于证据质量评级和推荐强度的新共识。
BMJ. 2008 Apr 26;336(7650):924-6. doi: 10.1136/bmj.39489.470347.AD.
Zotero 插件